This study effectively determined that BAP1, CDKN2A and NF2 alterations occur in pleural effusion-derived tumour cells at a higher frequency than what is typically seen in MM tumour samples, as well as identifying high frequency alterations for the TRAF7 and LATS2 genes. The gene discussed is CDKN2A; the disease is Miyoshi myopathy.